SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Q32 Bio, Inc. operates as a clinical stage biotechnology company developing biologic therapeutics targeting potent regulators of the innate and adaptive immune systems to re-balance immunity in autoimmune and inflammatory diseases. It focuses on the IL-7 / TSLP receptor pathways and complement system, addressing immune dysregulation to help patients take back control of their lives. The company was founded by David Grayzel and Shelia Violette in 2017 and is headquartered in Waltham, MA.

Q32 Bio Inc.

Q32 Bio is trending due to the sale of its experimental complement inhibitor to Akebia Therapeutics for up to several hundred million dollars, a move that is expected to significantly extend the company's cash runway. While some traders view the deal as a major validation of the pipeline and an attractive acquisition target, others are debating whether the market has already priced in the news or if potential dilution and short-interest dynamics will drive further volatility.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing significant volatility as the community remains divided between long-term investors tracking institutional accumulation and short-term traders reacting to persistent, algo-driven intraday price fluctuations. Investors are closely monitoring key support levels and the company's progress in expanding its fintech ecosystem as they await upcoming earnings reports.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is experiencing extreme volatility as investors weigh the impact of an upcoming 20-for-1 stock split against aggressive rebalancing moves by the South Korean National Pension Service. The community remains focused on the potential for a massive rally driven by the imminent U.S. listing of SK Hynix, even as leverage-induced selling and broader macro uncertainty fuel intense day-trading debates.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSMC is trending as investors digest blockbuster monthly revenue growth that highlights sustained, AI-driven demand for advanced chip manufacturing. Community discussion remains focused on the company's resilient fundamentals and price-hike potential despite broader market jitters over geopolitical risks.

SK hynix, Inc. engages in the manufacture and sale of semiconductor products. Its products include dynamic random access memory, flash memory, complementary metal oxide semiconductor image sensor, and others. The company was founded on October 15, 1949 and is headquartered in Icheon, South Korea.

SK Hynix Inc - ADR

SK Hynix is capturing significant market attention following its major ADR listing in the U.S., with investors closely monitoring its HBM market dominance as a key proxy for the broader AI infrastructure and memory cycle. While the community is debating potential entry points, much of the discourse centers on whether the stock will trade at a persistent premium compared to its domestic listing or if it will face immediate volatility similar to other high-profile tech IPOs.

Babcock & Wilcox Enterprises, Inc. engages in the provision of fossil and renewable power generation and environmental equipment. It operates through the B&W segment. The company was founded by George H. Babcock, Stephen Wilcox, Jr., and Joseph P. Manton in 1856 and is headquartered in Akron, OH.

Babcock & Wilcox Enterprises Inc

Babcock & Wilcox is trending as investors react to a new $50 million share repurchase program and ongoing volatility following an recent share offering. The community is actively debating the impact of the buyback on the company's valuation against concerns about legal class actions and the influence of major institutional holders.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Merck & Co. is currently the subject of intense buyout speculation, with investors betting the company will aggressively pursue acquisitions to bolster its oncology pipeline ahead of the looming Keytruda patent cliff. Community discussions are centered on potential targets like Sellas Life Sciences and Inhibrx, as stakeholders analyze whether Merck will prioritize high-growth biotech platforms to maintain its market dominance.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is experiencing high volatility as investors weigh the company's participation in the Pentagon's Drone Dominance Program against ongoing concerns regarding executive leadership and a lack of significant, transparent contract revenue. Community sentiment is deeply polarized, with many retail investors expressing frustration over the lack of sales updates while others remain bullish on the long-term defense sector thesis and potential for future military procurement.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending as investors react to a significant upward revision in Q2 revenue guidance, which sits well above market expectations and signals strong momentum across its AI infrastructure and contract pipeline. The community is heavily focused on the stock's high short interest, with many anticipating a potential short squeeze as they argue the company's fundamental shift toward contracted revenue and institutional-grade financing makes the current short position increasingly unsustainable.

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull is gaining attention as investors discuss a potential breakout driven by institutional platform expansion, the removal of specific day-trading restrictions, and ongoing share buyback programs. While some community members remain skeptical of the stock's performance compared to sector peers, many are actively debating whether these developments and positive sentiment around global growth will trigger a short squeeze or push the share price into double digits.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

VFF Stock Loses 27% in Three Months: Time to Invest or Exit?

Village Farms has slid 27% in three months despite strong international cannabis growth. Can European expansion outweigh rising competition and pricing risks?

Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $4.31, moving 1.6% from the previous trading session.

What Does Tilray Brands (TLRY) Gain From The HelloMD Corporation Acquisition?

What Does Tilray Brands (TLRY) Gain From The HelloMD Corporation Acquisition...

TLRY Plans Strategic Medical Cannabis Expansion: Time to Buy or Sell?

Tilray expands its medical cannabis strategy with HelloMD, adding virtual patient access as investors weigh growth potential against ongoing profitability challenges.

Tilray Brands, Inc. (TLRY) Suffers a Larger Drop Than the General Market: Key Insights

The latest trading day saw Tilray Brands, Inc. (TLRY) settling at $4.43, representing a -1.34% change from its previous close.

Tilray Brands, Inc. (TLRY) Sees a More Significant Dip Than Broader Market: Some Facts to Know

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $4.46, denoting a -2.83% move from the preceding trading day.

CRON Strengthens Global Footprint: Is the Cannabis Stock Worth Buying?

Cronos Group posts 40% Q1 revenue growth, gains share in Canada and expands abroad, but fierce cannabis competition keeps investors cautious.

Tilray Brands, Inc. (TLRY) Registers a Bigger Fall Than the Market: Important Facts to Note

In the closing of the recent trading day, Tilray Brands, Inc. (TLRY) stood at $4.59, denoting a -2.96% move from the preceding trading day.

Is Now a Good Time to Buy Tilray Brands Stock?

Is Now a Good Time to Buy Tilray Brands Stock...

Here's Why Tilray Brands, Inc. (TLRY) Fell More Than Broader Market

In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $4.88, marking a -2.59% move from the previous day.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

This US Cannabis Giant Is Launching Its First Premium Offering In Germany – Why It Matters?

Equity

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$4.42
Prev Close	$4.39
Open	$4.44
Dividend Yield	0.00%
50-Day Moving Average	$5.13
Beta	1.64
Avg. Volume	3.63M
PE Ratio	-0.32

52-Week High	$23.20
52-Week Low	$4.20
Market Capitalization	$530.41M
EPS (Annual)	-$24.56
Price to Book	0.33
Revenue Per Employee	$288,989.80

Feed

News

Sentiment

Earnings

Fundamentals

Info

TLRYTilray Brands Inc

Latest TLRY News